Post neoadjuvant therapy in Triple Negative Breast Cancer - report from SABCS2022

Professor Hope Rugo were speaker and co-author of several presentations at this years San Antonio Breast Cancer Symposium. We asked her about triple negative Breast Cancer. Where is the role of immunotherapy in early triple negative breast cancer? What is the benefit it can provide in the neoadjuvant and post-neoadjuvant setting on the basis of the current scientific evidence? Video: https://medicaldigest.org/scientific-contents/interview:post-neoadjuvant-therapy-triple-negative-breast-cancer